Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy

BACKGROUND & AIMS: Tristetraprolin (TTP) is a key post-transcriptional regulator of inflammatory and oncogenic transcripts. Accordingly, TTP was reported to act as a tumor suppressor in specific cancers. Herein, we investigated how TTP contributes to the development of liver inflammation and fib...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Mol Gastroenterol Hepatol
Main Authors: Dolicka, Dobrochna, Sobolewski, Cyril, Gjorgjieva, Monika, Correia de Sousa, Marta, Berthou, Flavien, De Vito, Claudio, Colin, Didier J., Bejuy, Olivia, Fournier, Margot, Maeder, Christine, Blackshear, Perry J., Rubbia-Brandt, Laura, Foti, Michelangelo
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7806869/
https://ncbi.nlm.nih.gov/pubmed/32987153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2020.09.012
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki